Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Alimta
Active Ingredient: Pemetrexed sodium 151.7mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Eli Lilly and Co, Lilly Technology Centre, Indianapolis, Indiana, United States of America
Product: Apo-Desloratadine
Active Ingredient: Desloratadine 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Lupin Limited, Verna, Salcette, Goa, India
Product: Aspirin
Active Ingredient: Aspirin 75mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Cipla Limited, Manufacturing Division, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product: Flexicart
Active Ingredient: Sodium bicarbonate 100%w/w
Dosage Form: Powder for dialysis solution
New Zealand Sponsor: Fresenius Medical Care Australia Pty Limited
Manufacturer: Fresenius SMAD, Secteur Ouest, L’Arbresle Cede, France
Product: Reyataz
Active Ingredient: Atazanavir sulfate 341.69mg equivalent to 300mg atazanavir
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer: Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Product: SimvaRex
Active Ingredient: Simvastatin 80mg
Dosage Form: Coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Manufacturing Division, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Dated this 6th day of May 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).